摘要 |
A compound represented by the general formula (I) and a salt thereof which is used as an activating agent for peroxisome proliferator activated receptor (PPAR) delta is disclosed, wherein the variables are as defined in the specification. These compounds of formula (I) are suitable treating a disease mediated by peroxisome proliferator activated receptor delta is hyperlipidemia, dyslipidemia, hyperchlolesterolemia, hypertriglyceridemia, HDL hypocholesterolemia, LDL hypercholesterolemia and/or HLD noncholesterolemia, VLDL hyperproteinemia, dyslipoproteinemia, apolipoprotein A-I hypoproteinemia, atherosclerosis, disease of arterial sclerosis, disease of cardiovascular systems, cerebrovascular disease, peripheral circulatory disease, metabolic syndrome, syndrome X, obesity including internal-organs fat type, diabetes, hyperglycemia, insulin resistance, impaired glucose tolerance, hyperinsulinism, diabetic complication, cardiac insufficiency, cardiac infarction, cardiomyopathy, hypertension, fatty liver, non-alcoholic fatty hepatitis, thrombus, Alzheimer disease, neurodegenerative disease, demyelinating disease, multiple sclerosis, adrenal leukodystrophy, dermatitis, psoriasis, acne, skin aging, trichosis, inflammation, arthritis, asthma, hypersensitive intestine syndrome, ulcerative colitis, Crohn's disease, pancreatitis, or cancer including colon cancer, large intestine cancer, skin cancer, cancer of the breast, carcinoma of the prostate, ovary cancer, or lung cancer.
|
申请人 |
NIPPON CHEMIPHAR CO., LTD. |
发明人 |
SAKUMA, SHOGO;MOCHIDUKI, NOBUTAKA;USHIODA, MASATOSHI;TAKAHASHI, RIE;YAMAKAWA, TOMIO;MASUI, SEIICHIRO |